Want to see IN:BODALCHEM full AI Analyst Report?
Top Page
Bodal Chemicals Limited
(BODALCHEM)
Select Model
Select Model
Rating:57Neutral
Price Target:
₹190.00
▲(251.46% Upside)
Action:Reiterated
Date:09/09/26
The score is driven primarily by improving but still uneven financial performance (cyclical margins, meaningful leverage, and historically inconsistent free cash flow despite FY2026 improvement). Technicals are supportive due to a strong uptrend, but extremely overbought readings temper the outlook. Valuation is a headwind given the elevated P/E and no dividend yield data.
Positive Factors
Revenue Growth
Two consecutive years of revenue growth indicate improving demand or realizations after earlier volatility. Continued top-line expansion can support better utilization of the company’s dye and dye-intermediate operations, although the durability of this trend remains linked to end-market conditions.
Negative Factors
Meaningful Leverage
A substantial debt balance reduces financial flexibility and can make the company more sensitive to weaker earnings or higher financing costs. Although equity exceeds debt, rising leverage relative to the capital base may constrain future investment and capital allocation choices.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Two consecutive years of revenue growth indicate improving demand or realizations after earlier volatility. Continued top-line expansion can support better utilization of the company’s dye and dye-intermediate operations, although the durability of this trend remains linked to end-market conditions.
Read all positive factors
Bodal Chemicals Limited (BODALCHEM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹21.52B
Dividend Yield0.13%
Average Volume (3M)198.83K
Price to Earnings (P/E)33.8
Beta (1Y)1.13
Revenue Growth27.57%
EPS Growth135.05%
CountryIN
Employees2,133
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)5.45
Shares Outstanding125,944,060
10 Day Avg. Volume550,913
30 Day Avg. Volume198,831
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)0.56
Price to Sales (P/S)0.32
P/FCF Ratio8.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.1
Revenue Forecast (FY)₹22.23B
Bodal Chemicals Limited Business Overview & Revenue Model
Company Description
Bodal Chemicals Limited, an Indian enterprise, produces and supplies a range of chemicals, including dyestuffs, dye intermediates, and various other chemical products. Its comprehensive portfolio of dye intermediates features key compounds such as...
How the Company Makes Money
Bodal Chemicals makes money by manufacturing and selling chemical products, with revenue primarily derived from (1) dyes and (2) dye intermediates. In this model, the company earns sales income by supplying finished dyes (used by customers such as...
Bodal Chemicals Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
55
Neutral
Cash Flow
48
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.67B | 20.12B | 17.45B | 13.95B | 15.63B | 20.27B |
| Gross Profit | 8.19B | 7.04B | 6.76B | 1.68B | 6.70B | 5.42B |
| EBITDA | 2.07B | 1.68B | 1.69B | 1.19B | 1.45B | 2.16B |
| Net Income | 686.74M | 478.28M | 185.02M | 64.69M | 380.33M | 1.04B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 23.56B | 23.53B | 22.88B | 21.21B | 21.22B |
| Cash, Cash Equivalents and Short-Term Investments | 212.87M | 212.87M | 360.60M | 462.50M | 225.87M | 93.95M |
| Total Debt | 0.00 | 8.13B | 9.11B | 8.47B | 6.98B | 5.76B |
| Total Liabilities | -11.58B | 11.98B | 12.48B | 12.06B | 10.43B | 10.70B |
| Stockholders Equity | 11.58B | 11.58B | 11.05B | 10.82B | 10.78B | 10.56B |
Cash Flow | ||||||
| Free Cash Flow | 587.21M | 743.38M | -83.36M | -407.19M | -528.49M | -1.73B |
| Operating Cash Flow | 778.82M | 1.10B | 381.14M | 2.04B | 2.85B | -135.20M |
| Investing Cash Flow | 75.41M | -13.37M | -424.34M | -2.62B | -3.10B | -1.70B |
| Financing Cash Flow | -920.92M | -1.14B | 76.36M | 809.81M | 326.55M | 1.81B |
Bodal Chemicals Limited Technical Analysis
Positive
54.06
Price Trends
78.51
Positive
73.92
Positive
62.78
Positive
Market Momentum
22.47
Negative
96.37
Negative
94.17
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Positive. The current price of 54.06 is below the 20-day moving average (MA) of 97.95, below the 50-day MA of 78.51, and below the 200-day MA of 62.78, indicating a bullish trend. The MACD of 22.47 indicates Negative momentum. The RSI at 96.37 is Negative, neither overbought nor oversold. The STOCH value of 94.17 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BODALCHEM.
Bodal Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹65.98B | 48.70 | ― | 0.22% | 91.44% | 19.67% | |
61 Neutral | ₹98.84B | 133.23 | ― | 0.78% | 90.13% | -6.80% | |
57 Neutral | ₹25.37B | 16.70 | ― | 0.11% | 19.47% | 11.49% | |
57 Neutral | ₹21.52B | 33.78 | ― | 0.13% | 27.57% | 135.05% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
42 Neutral | ₹19.57B | 400.58 | ― | 0.47% | 8.40% | ― |
* General Sector Average
IN:BODALCHEM
Bodal Chemicals Limited
184.20
118.46
180.19%
IN:CAMLINFINE
Camlin Fine Sciences Limited
104.20
-111.30
-51.65%
IN:FCL
Fineotex Chemical Limited
58.35
34.26
142.25%
IN:SUDARCOLOR
Heubach Colorants India Limited
383.00
-212.10
-35.64%
IN:ROSSARI
Rossari Biotech Ltd
454.55
-179.14
-28.27%
IN:SUDARSCHEM
Sudarshan Chemical Industries Limited
1,222.65
-177.59
-12.68%
Bodal Chemicals Limited Corporate Events
Bodal Chemicals Sets Virtual AGM to Approve FY26 Accounts and Board Changes
Aug 31, 2026
Bodal Chemicals Limited has scheduled its 40th Annual General Meeting for September 25, 2026, to be conducted via video conferencing and other audio-visual means in line with regulatory allowances for virtual meetings. The company is distributing ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.